Pharmabiz4h
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy
Takeda’s flagship GICC to create 750 jobs, foster technological innovation with emphasis on plasma-based therapy: Our Bureau, ...
Pharmabiz5h
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients
Gleneagles Hospital performs Mumbai’s first domino kidney transplant of the year for sensitized patients: Our Bureau, Mumbai ...
Pharmabiz1d
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz1d
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz1d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz1d
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma
China NMPA approves Sanofi’s Sarclisa in combo with pomalidomide and dexamethasone to treat adult patients with R/R multiple myeloma: Paris Tuesday, January 14, 2025, 10:00 Hrs ...
Pharmabiz4h
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research
Tata Group partners with IISc investing Rs. 500 crore to set-up medical school to pioneer healthcare education and research: Our Bureau, Bengaluru Wednesday, January 15, 2025, 17: ...
Pharmabiz23h
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz4h
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2
NIH-funded study finds cases of ME/CFS increase following SARS-CoV-2: Maryland Wednesday, January 15, 2025, 17:00 Hrs [IST] New findings from the National Institutes of Health’s ...
Pharmabiz3h
Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease
Vivoryon Therapeutics provides R&D-update further strengthening development pipeline in kidney disease: Munich, Germany Wednesday, January 15, 2025, 18:00 Hrs [IST] Vivoryon Thera ...
Pharmabiz6h
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy
Santhera gets positive recommendation from Scottish Medicines Consortium for use of Agamree to treat Duchenne muscular dystrophy: Pratteln, Switzerland Wednesday, January 15, 2025 ...
Pharmabiz6d
Parliamentary panel asks PMBI to take steps to ensure quality of drugs sold through JAKs
The Parliamentary panel that reviewed the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has sought the Pharmaceuticals & Medical Devices Bureau of India (PMBI), the ...